Nu Skin Enterprises Inc (NUS) (Q3 2026) Earnings Call Highlights: Prism Momentum
Nu Skin (NUS) reported Q3 2026 revenue of $311M, adjusted EPS of $0.10, within guidance. Prism scan-to-purchase conversion rate doubled to 10% post-app update. Gross margin declined to 65% due to revenue mix. Q4 revenue guided to $310M-$340M, FY2026 revenue expected at $1.26B-$1.29B. East-West model transition costs expected at $5M in Q4. India launch planned for H1 2027.
How this was made
The 30-second read
Why it matters
The modest guidance and margin decline suggest short‑term pressure, but long‑term growth from AI‑enabled Prism devices could offset concerns.
Market read
Earnings and guidance provide fresh data for traders; the stock may face near‑term downside but has longer‑term catalysts.
What to watch
Potential upside from upcoming India launch and new anti‑aging product pipeline not reflected in guidance
Background
Nu Skin Enterprises held its Q3 2026 earnings call, reporting revenue, margin, and guidance details.
Ticker impact
Q3 earnings released with gross margin decline and new Q4/full‑year 2026 guidance
likely downside as investors price in weaker margin and modest guidance
Q4 revenue guidance of $310‑$340 M and adjusted EPS $0.11‑$0.21 are modest; gross margin fell to 65% from 70.5%, suggesting pressure on profitability
Market effects
Highlights challenges for the personal‑care/beauty sector with margin compression
North American and Asian markets may see modest reaction given Nu Skin's global footprint
Limited to investors tracking mid‑cap consumer‑health stocks
Counterpoint
Guidance may be overly cautious; AI‑driven Prism platform could accelerate growth beyond current forecasts
Key entities
- companyNu Skin Enterprises Inc
US‑listed personal‑care and nutrition company
